𝔖 Bobbio Scriptorium

✦ LIBER ✦

Improving adherence to surveillance and screening recommendations for people with colorectal cancer and their first degree relatives: a randomized controlled trial

✍ Scribed by Mariko Carey; Rob Sanson-Fisher; Finlay Macrae; David Hill; Catherine D’Este; Christine Paul; Christopher Doran

Book ID: 115010447
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 115 KB
Volume: 12
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-12-62

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PO.29 COLORECTAL CANCER PREVENTION WITH

PO.29 COLORECTAL CANCER PREVENTION WITH SCREENING PROGRAMS ALLOW IDENTIFICATION AND SURVEILLANCE OF FIRST-DEGREE RELATIVES WITH INCREASED RISK FOR COLORECTAL CANCER

✍ N. Fusetti; V.G. Matarese; L. Simone; L. Trevisani; V. Cifalà; A. Pezzoli; S. Gu 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Are Tri-Ethnic Low-Income Women with Bre

Are Tri-Ethnic Low-Income Women with Breast Cancer Effective Teachers of the Importance of Breast Cancer Screening to Their First-Degree Relatives? Results from a Randomized Clinical Trial

✍ Denise M. Oleske; Angel Galvez; Melody A. Cobleigh; Pamela Ganschow; Laurie D. A 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB

Pre-operative chemo-radiotherapy improve

Pre-operative chemo-radiotherapy improves 3-year survival in people with resectable oesophageal cancer: Abstracted from: Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemo-radiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003;185:538–43

✍ P Naughton; T.N Walsh 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB